Onconetix Ownership 2024 | Who Owns Onconetix Now?
Institutional Ownership
15.46%
Insider Ownership
17.69%
Retail Ownership
66.85%
Institutional Holders
17.00
Onconetix Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -128 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA SECURITIES, LLC | - | - | - | -113,434 | -100.00% | - | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -27,721 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -3,599 | -100.00% | - | Jun 30, 2024 |
Onconetix's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -128 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA SECURITIES, LLC | - | - | - | -113,434 | -100.00% | - | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -27,721 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -3,599 | -100.00% | - | Jun 30, 2024 |
The largest Onconetix shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Onconetix (BWV), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -128 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -3,599 | -100.00% | - | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -27,721 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA SECURITIES, LLC | - | - | - | -113,434 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Onconetix's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.13K stocks of BWV, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TWO SIGMA SECURITIES, LLC | - | - | - | -113,434 | -100.00% | - | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -27,721 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -3,599 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -128 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Onconetix's biggest institutional seller is TWO SIGMA SECURITIES, LLC. The company sold -0.11M shares of BWV, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TWO SIGMA SECURITIES, LLC | - | - | - | -113,434 | -100.00% | - | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -27,721 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -3,599 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -128 | -100.00% | - | Jun 30, 2024 |
Onconetix's largest sold out institutional shareholder by shares sold is TWO SIGMA SECURITIES, LLC, sold -0.11M shares, valued at -, as of undefined.
Onconetix Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 52,400 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 73,513 | -73,513 | -50.00% | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 314 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 16,680 | - | - | Mar 31, 2024 |
Onconetix's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 52.40K shares, compromising 0.00% of its total assets.
Onconetix Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 17 | -19.05% |
31 Dec, 23 | 21 | 16.67% |
30 Sep, 23 | 18 | -5.26% |
30 Jun, 23 | 19 | 46.15% |
31 Mar, 23 | 13 | -27.78% |
31 Dec, 22 | 18 | 20.00% |
30 Sep, 22 | 15 | 87.50% |
30 Jun, 22 | 8 | -38.46% |
31 Mar, 22 | 13 | - |
As of 31 Mar 24, 17 institutions are holding Onconetix's shares, representing a decrease of -19.05% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 2,709,169 | 11.86% |
31 Dec, 23 | 2,421,823 | -32.08% |
30 Sep, 23 | 3,565,693 | 49.15% |
30 Jun, 23 | 2,390,647 | 47.56% |
31 Mar, 23 | 1,620,167 | -16.32% |
31 Dec, 22 | 1,936,159 | -17.87% |
30 Sep, 22 | 2,357,568 | 111.55% |
30 Jun, 22 | 1,114,438 | 143.56% |
31 Mar, 22 | 457,557 | - |
Onconetix (BWV) has 2.71M shares outstanding as of 31 Mar 24, up 11.86% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 15.46% | 8.09% |
31 Dec, 23 | 13.82% | 3.34% |
30 Sep, 23 | 20.35% | 9.01% |
30 Jun, 23 | 15.03% | 14.49% |
31 Mar, 23 | 10.18% | 4.09% |
31 Dec, 22 | 15.78% | 5.84% |
30 Sep, 22 | 16.44% | 19.05% |
30 Jun, 22 | 9.29% | 17.83% |
31 Mar, 22 | 7.22% | - |
As of 31 Mar 24, Onconetix is held by 15.46% institutional shareholders, representing a 8.09% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | 6 | -14.29% |
31 Dec, 23 | 7 | -22.22% |
30 Sep, 23 | 9 | -40.00% |
30 Jun, 23 | 15 | 114.29% |
31 Mar, 23 | 7 | -41.67% |
31 Dec, 22 | 12 | -7.69% |
30 Sep, 22 | 13 | 85.71% |
30 Jun, 22 | 7 | -46.15% |
31 Mar, 22 | 13 | - |
6 institutional shareholders have increased their position in BWV stock as of 31 Mar 24 compared to 7 in the previous quarter (a -14.29% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | 2 | -50.00% |
31 Dec, 23 | 4 | 33.33% |
30 Sep, 23 | 3 | - |
30 Jun, 23 | 3 | 50.00% |
31 Mar, 23 | 2 | -50.00% |
31 Dec, 22 | 4 | 100.00% |
30 Sep, 22 | 2 | - |
30 Jun, 22 | - | - |
31 Mar, 22 | - | - |
2 institutional shareholders have reduced their position in BWV stock as of 31 Mar 24 compared to 4 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 17 | -19.05% | 2,709,169 | 11.86% | 15.46% | 8.09% | 6 | -14.29% | 2 | -50.00% |
31 Dec, 23 | 21 | 16.67% | 2,421,823 | -32.08% | 13.82% | 3.34% | 7 | -22.22% | 4 | 33.33% |
30 Sep, 23 | 18 | -5.26% | 3,565,693 | 49.15% | 20.35% | 9.01% | 9 | -40.00% | 3 | - |
30 Jun, 23 | 19 | 46.15% | 2,390,647 | 47.56% | 15.03% | 14.49% | 15 | 114.29% | 3 | 50.00% |
31 Mar, 23 | 13 | -27.78% | 1,620,167 | -16.32% | 10.18% | 4.09% | 7 | -41.67% | 2 | -50.00% |
31 Dec, 22 | 18 | 20.00% | 1,936,159 | -17.87% | 15.78% | 5.84% | 12 | -7.69% | 4 | 100.00% |
30 Sep, 22 | 15 | 87.50% | 2,357,568 | 111.55% | 16.44% | 19.05% | 13 | 85.71% | 2 | - |
30 Jun, 22 | 8 | -38.46% | 1,114,438 | 143.56% | 9.29% | 17.83% | 7 | -46.15% | - | - |
31 Mar, 22 | 13 | - | 457,557 | - | 7.22% | - | 13 | - | - | - |
Onconetix Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Onconetix's stock was made by Schiess Ralph on Jan 03 2024, selling - shares at - per share (valued at -).
Onconetix Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2023 | 7 | 1 | 700.00% |
Q1 2023 | 1 | - | - |
Q4 2022 | 1 | 1 | 100.00% |
Q3 2022 | 2 | 5 | 40.00% |
Q2 2022 | 7 | - | - |
Q1 2022 | 1 | 6 | 16.67% |
7 total buy trades, and 1 total sell trades (buy/sell ratio of 7.00%) were made by Onconetix's insiders, as of Q2 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | 3 | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Onconetix's stocks.
Onconetix Peer Ownership
Ticker | Company |
---|---|
BDRX | Biodexa Pharmaceuticals Plc |
KPRX | Kiora Pharmaceuticals, Inc. |
PXMD | PaxMedica, Inc. Common Stock |
REVB | Revelation Biosciences, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
HILS | Tharimmune, Inc. |
VRAX | Virax Biolabs Group Limited |
ALLR | Allarity Therapeutics, Inc. |
UNCY | Unicycive Therapeutics, Inc. |
CDIO | Cardio Diagnostics Holdings, Inc. |
PALI | Palisade Bio, Inc. |
BWV Ownership FAQ
Who Owns Onconetix?
Onconetix is owned by institutional shareholders (15.46%), insiders (17.69%), and public (66.85%). The largest institutional shareholder of Onconetix is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Onconetix?
Onconetix's major institutional shareholders are WELLS FARGO & COMPANY/MN, TWO SIGMA SECURITIES, LLC, VIRTU FINANCIAL LLC, and UBS GROUP AG. The top five shareholders own together 0% of the company's share outstanding.
How many Onconetix shareholders are there?
As of Mar 2024, there are 17 institutional shareholders of Onconetix.
What percentage of Onconetix is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 0 shares of Onconetix, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Onconetix is owned by TWO SIGMA SECURITIES, LLC?
As of Jun 2024, TWO SIGMA SECURITIES, LLC holds 0 shares of Onconetix (BWV), compromising 0% of the company, valued at $0.
What percentage of Onconetix is owned by VIRTU FINANCIAL LLC?
VIRTU FINANCIAL LLC is the third largest holder of Onconetix. The company owns 0 of the company's shares outstanding (worth $0).